Loading...
Dimerix Limited
DXB.AX•ASX
Healthcare
Biotechnology
A$0.48
A$0.01(2.13%)
Dimerix Limited (DXB.AX) Financial Performance & Income Statement Overview
Review Dimerix Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-93.51%
↓ 93.51%
Operating Income Growth
-9.80%
↓ 9.80%
Net Income Growth
-23.71%
↓ 23.71%
Operating Cash Flow Growth
44.98%
↑ 44.98%
Operating Margin
-4254.53%
↓ 4254.53%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-3159.02%
↓ 3159.02%
ROE
-183.87%
↓ 183.87%
ROIC
-180.89%
↓ 180.89%
Dimerix Limited (DXB.AX) Income Statement & Financial Overview
Review Dimerix Limited's (DXB.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $450418.00 | $133060.00 | $8.98M | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $450418.00 | $133060.00 | $8.98M | $0.00 |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $0.00 |
| R&D Expenses | $16.02M | $5.08M | $11.89M | $8.59M |
| SG&A Expenses | $2.73M | $1.82M | $1.25M | $1.10M |
| Operating Expenses | $18.75M | $6.90M | $13.14M | $9.68M |
| Total Costs & Expenses | $18.75M | $6.90M | $13.14M | $9.68M |
| Interest Income | $138035.00 | $37977.00 | $10240.00 | $26547.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $4026.00 | $2247.00 | $2778.00 | $1715.00 |
| EBITDA | -$10.36M | -$6.71M | -$4.19M | -$9.63M |
| EBITDA Ratio | -$23.001 | -$50.42 | -$0.47 | $0.00 |
| Operating Income | -$18.30M | -$6.76M | -$13.14M | -$9.68M |
| Operating Income Ratio | -$40.62 | -$50.83 | -$1.46 | $0.00 |
| Other Income/Expenses (Net) | $7.89M | $90463.00 | $8.94M | $75651.00 |
| Income Before Tax | -$10.40M | -$6.67M | -$4.19M | -$9.61M |
| Income Before Tax Ratio | -$23.09 | -$50.15 | -$0.47 | $0.00 |
| Income Tax Expense | $0.00 | $52486.00 | $8.93M | $49104.00 |
| Net Income | -$10.40M | -$6.67M | -$4.19M | -$9.61M |
| Net Income Ratio | -$23.09 | -$50.15 | -$0.47 | $0.00 |
| EPS | -$0.02 | -$0.02 | -$0.01 | -$0.03 |
| Diluted EPS | -$0.02 | -$0.02 | -$0.01 | -$0.03 |
| Weighted Avg Shares Outstanding | $500.10M | $405.74M | $336.72M | $326.57M |
| Weighted Avg Shares Outstanding (Diluted) | $500.08M | $405.74M | $336.72M | $326.57M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan